At the World Vaccine Congress 2023 held in Washington, USA from April 3-6, Bharat Biotech was awarded the Best Production/Process Development award as a part of the Vaccine Industry Excellence (ViE) awards.
Bharat Biotech, headquartered in Hyderabad, was the sole Indian company among the nominees for the VIE awards in multiple categories such as the best clinical trial company, best clinical trial network, best central/specialty laboratory, best contract research organisation, and best production/process development, among others. Bharat Biotech is known for developing the world’s first intranasal Covid-19 vaccine, iNcovacc, and its intramuscular vaccine, Covaxin, which is used in India’s public vaccination programme and has also been exported.
About the World Vaccine Congress
The World Vaccine Congress is a major international conference focused on vaccines, covering the entire vaccine value chain from basic research to commercial manufacturing. It brings together experts from all over the world to share their knowledge and expertise in vaccine development. The conference has been particularly important in addressing the COVID-19 pandemic and has been a platform for sharing groundbreaking discoveries and insights.
Important takeaways for all competitive exams: